Furthermore, in the LLC-derived tumor model, ectopic VEGFR2 expression antagonized the decreased CD31-positive vessel density occurring with FUNDC1 deficiency, thus enhancing tumor growth and reversing the reduced tumor size (Fig. 4h, i). This evidence concerns the gene FUNDC1 and neoplasm.